Cytokine release syndrome occurred in 70% of patients, with lower incidence in those pre-treated with 2,000 mg Gazyva. Severe ...

A range of medications are available to help treat lupus nephritis (LN), each offering a specific role in managing the ...

Basel, 05 November 2024 - Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that it will present more than 40 abstracts across nine blood disorders at the 66th American Society of Hematology (ASH) ...

NEW YORK, Oct. 29, 2024 /PRNewswire/ -- Canopy, the first Continuous Care Platform for oncology, today announced the strategic expansion of its leadership team with the appointments of Josh Neiman ...

Novartis and Apellis Pharmaceuticals have rolled out detailed data on iptacopan and pegcetacoplan, respectively, as they race for the prize in a type of rare kidney disease. Saturday, Apellis laid ...

In these studies, there were 83.1% of patients in the obinutuzumab group and 63.4% in the rituximab group who achieved MRD negativity by bone marrow testing. In the study, researchers used ...